¿Û¿Û´«Ã½

Dan Jones explains what an American quality share should look like in an era when AI dominates the S&P 500

It faces threats, but there are reasons why the Sage of Omaha has owned this stock for 25 years

Its weight-loss drugs are more accessible, and it has secured tariff exemptions

Investors will need deep pockets to take a stake in this prodigious compounder, but it’s worth it

Its shares are down due to macro worries, but the company is quickly moving to a less cyclical model